Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,903.50    -9.50 (-0.50%)
Bid:
1,904.00
Ask:
1,905.00
Spread: 1.00 (0.053%)
Market Cap: £76.34b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON MARKET MIDDAY: FTSE 100 edges up, gold gleams and GSK shines
5 Feb 2025

LONDON MARKET MIDDAY: FTSE 100 edges up, gold gleams and GSK shines

(Alliance News) - Stock prices in London were mixed on Wednesday afternoon, with a share price rise for GSK supporting the FTSE 100, though tariff wor...

LONDON MARKET OPEN: GSK adds impetus but FTSE 100 struggles
5 Feb 2025

LONDON MARKET OPEN: GSK adds impetus but FTSE 100 struggles

(Alliance News) - London's FTSE 100 made a slow start on Wednesday, with trade worries keeping positivity at bay again, while GSK was a standout perfo...

GSK boosts long-term sales target as 2024 revenue beats expectations
5 Feb 2025

GSK boosts long-term sales target as 2024 revenue beats expectations

(Alliance News) - GSK PLC on Wednesday raised its long-term sales guidance and announced a GBP2 billion share buyback, reflecting optimism about its l...

LONDON BRIEFING: GSK hails pipeline as ups 2031 sales target
5 Feb 2025

LONDON BRIEFING: GSK hails pipeline as ups 2031 sales target

(Alliance News) - European blue-chips are set for a softer open, as the equity market continues to be marred by trade tensions this week.

GSK ups five-year sales outlook, but 2024 results come up short
5 Feb 2025

GSK ups five-year sales outlook, but 2024 results come up short

(Sharecast News) - GSK's annual revenues were held back weak vaccines sales, but shares in the pharma giant jumped on Wednesday after the company unve...

IN BRIEF: Indivior completes USD100 million share buyback
4 Feb 2025

IN BRIEF: Indivior completes USD100 million share buyback

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use disorders - Completes share buyback programme begun in July. Indivio...

BioVersys launches IPO seeking to raise 80 mln Swiss francs
29 Jan 2025

BioVersys launches IPO seeking to raise 80 mln Swiss francs

ZURICH, Jan 29 (Reuters) - Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange ...